运动作为精神分裂症患者的附加治疗:来自大型多中心随机对照试验的结果
Isabel Maurus1, Lukas Roell2, Moritz Lembeck1
1Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
Psychiatry research
|September 16, 2023
概括
有氧耐力训练 (AET) 在改善精神分裂症患者的结果方面没有超过灵活性训练. 然而,这两种运动类型都在症状,认知和功能方面都有好处,支持在精神分裂症治疗中炼整合.
科学领域:
- 精神病学是一个精神病学.
- 运动科学 运动科学
- 临床心理学 临床心理学
背景情况:
- 目前的精神分裂症治疗往往无法完全恢复,导致持续的负面症状和认知缺陷.
- 有氧耐力训练 (AET) 是作为精神分裂症患者身心健康的补充疗法.
- 精神分裂症的治疗需要新的方法来解决残留症状并改善患者的功能.
研究的目的:
- 评估有氧耐力训练 (AET) 作为稳定精神分裂症患者的补充治疗的有效性.
- 将AET与灵活性,强化和平衡训练 (FSBT) 对临床结果,认知和功能进行比较.
- 评估运动干预对精神病理学,认知缺陷和精神分裂症心血管风险的影响.
主要方法:
- 进行了一项大规模的,多中心的,评估者盲目的,并行组随机对照试验.
- 180名患有稳定精神分裂症的参与者被随机分配到六个月的AET计划或FSBT对照组.
- 在干预后的另外六个月内进行了后续评估.
主要成果:
- 有氧耐力训练 (AET) 没有优于灵活性,强化和平衡训练 (FSBT) 在任何原因停止或大多数次要结果方面.
- 两组AET和FSBT都在积极,一般和总体精神症状,功能和认知表现方面显著改善.
- 更高的训练频率与增强的记忆功能相关,具有更好的基线认知能力的个体对干预措施的反应更大.
结论:
- 运动干预措施,包括AET和FSBT,在改善精神分裂症患者的症状,认知和功能方面表现有前途.
- 虽然AET没有显示出优于FSBT的优势,但研究结果支持将运动纳入精神分裂症治疗方案.
- 未来的研究应该专注于个性化的运动建议,以最大限度地提高精神分裂症患者的益处.
相关概念视频
Drug Therapy
68
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
68
Electroconvulsive Therapy
68
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
68
Schizophrenia
109
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
109
Psychosis: Goals of Pharmacotherapy
165
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
165
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295


